Application of Heterogeneity of Treatment-Effects Methods: Exploratory Analyses of a Trial of Exercise-Based Interventions for Knee Osteoarthritis.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
08 2022
Historique:
revised: 02 11 2020
received: 15 05 2020
accepted: 14 01 2021
pubmed: 20 1 2021
medline: 28 7 2022
entrez: 19 1 2021
Statut: ppublish

Résumé

To evaluate heterogeneity of treatment effects in a trial of exercise-based interventions for knee osteoarthritis (OA). Participants (n = 350) were randomized to standard physical therapy (PT; n = 140), internet-based exercise training (IBET; n = 142), or wait list (WL; n = 68) control. We applied qualitative interaction trees (QUINT), a sequential partitioning method, and generalized unbiased interaction detection and estimation (GUIDE), a regression tree approach, to identify subgroups with greater improvements in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score over 4 months. Predictors included 24 demographic, clinical, and psychosocial characteristics. We conducted internal validation to estimate optimism (bias) in the range of mean outcome differences among arms. Both QUINT and GUIDE indicated that for participants with lower body mass index (BMI), IBET was better than PT (improvements of WOMAC ranged from 6.3 to 9.1 points lower), and for those with higher BMI and a longer duration of knee OA, PT was better than IBET (WOMAC improvement was 6.3 points). In GUIDE analyses comparing PT or IBET to WL, participants not employed had improvements in WOMAC ranging from 1.8 to 6.8 points lower with PT or IBT versus WL. From internal validation, there were large corrections to the mean outcome differences among arms; however, after correction, some differences remained in the clinically meaningful range. Results suggest there may be subgroups who experience greater improvement in symptoms from PT or IBET, and this finding could guide referrals and future trials. However, uncertainty persists for specific treatment-effects size estimates and how they apply beyond this study sample.

Identifiants

pubmed: 33463020
doi: 10.1002/acr.24564
pmc: PMC8286274
mid: NIHMS1664165
doi:

Banques de données

ClinicalTrials.gov
['NCT02312713']

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1359-1368

Subventions

Organisme : Patient-Centered Outcomes Research Institute
ID : CER-1306-02043
Pays : United States
Organisme : HSRD VA
ID : IK6 HX002838
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR072580
Pays : United States

Informations de copyright

© 2021 American College of Rheumatology.

Références

Arthritis Rheum. 2001 Aug;45(4):384-91
pubmed: 11501727
Int J Biostat. 2016 May 1;12(1):45-63
pubmed: 27227717
Osteoarthritis Cartilage. 2019 Nov;27(11):1578-1589
pubmed: 31278997
Lancet. 2005 Jan 8-14;365(9454):176-86
pubmed: 15639301
Arthritis Care Res (Hoboken). 2020 Feb;72(2):149-162
pubmed: 31908149
Psychother Res. 2016 Sep;26(5):612-22
pubmed: 26169837
Br J Sports Med. 2015 Dec;49(24):1554-7
pubmed: 26405113
Osteoarthritis Cartilage. 2018 Mar;26(3):383-396
pubmed: 29307722
Stat Med. 2017 Jan 15;36(1):136-196
pubmed: 27488683
Clin Exp Rheumatol. 2019 Sep-Oct;37 Suppl 120(5):64-72
pubmed: 31621574
Phys Ther. 2014 Jan;94(1):31-9
pubmed: 23929827
Psychol Methods. 2009 Dec;14(4):323-48
pubmed: 19968396
J Orthop Sci. 2013 Nov;18(6):932-9
pubmed: 24085378
Arthritis Care Res (Hoboken). 2015 Sep;67(9):1281-1288
pubmed: 25623617
BMJ. 2010 Mar 30;340:c117
pubmed: 20354011
Stat Med. 2014 Jan 30;33(2):219-37
pubmed: 23922224
BMC Musculoskelet Disord. 2018 Jul 19;19(1):238
pubmed: 30025540
BMJ Open. 2017 Dec 22;7(12):e018971
pubmed: 29275348
Arthritis Care Res (Hoboken). 2014 Jan;66(1):63-8
pubmed: 23982988
Stat Med. 2015 May 20;34(11):1818-33
pubmed: 25656439
Behav Res Methods. 2016 Jun;48(2):650-63
pubmed: 26092391
Stat Med. 2016 Nov 20;35(26):4837-4855
pubmed: 27346729
Br J Sports Med. 2019 Sep;53(18):1141-1153
pubmed: 30862704
BMC Musculoskelet Disord. 2015 Sep 28;16:264
pubmed: 26416025
Phys Ther. 2011 Apr;91(4):510-24
pubmed: 21310898

Auteurs

Cynthia J Coffman (CJ)

Durham Veterans Administration Healthcare System and Duke University Medical Center, Durham, North Carolina.

Liubov Arbeeva (L)

University of North Carolina at Chapel Hill.

Todd A Schwartz (TA)

Gillings School of Global Public Health, University of North Carolina at Chapel Hill.

Leigh F Callahan (LF)

University of North Carolina at Chapel Hill.

Yvonne M Golightly (YM)

University of North Carolina at Chapel Hill.

Adam P Goode (AP)

Duke University School of Medicine and Duke University Medical Center, Durham, North Carolina.

Kim M Huffman (KM)

Duke University Medical Center, Durham, North Carolina.

Kelli D Allen (KD)

University of North Carolina at Chapel Hill and Durham Veterans Administration Healthcare System, Durham, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH